Eric Aguiar
Director at BridgeBio Pharma, Inc. (BBIO)
Eric Aguiar has filed 14 insider reports with the SEC since May 2021, as director at BridgeBio Pharma, Inc. (BBIO), director at Biomea Fusion, Inc. (BMEA) and director at Invitae Corp (NVTA). The latest filing, on June 24, 2026, reports grant or award at BridgeBio Pharma, Inc. (BBIO).
- Filings
- 14
- Companies
- 3
- Bought on market
- None
- Sold on market
- None
Companies where Eric Aguiar is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Director | 10,579 | $76.03 | Jun 24, 2026 | ||||
| Director | $0.5744 | Jun 12, 2026 | |||||
| Director | 125,322 | May 1, 2023 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Jun 22, 2026BBIODirector Aguiar Eric was granted 3,990 shares, increasing direct ownership by 61% to 10,579 unitsForm 4Grant or award
- Jun 10, 2026BMEASEC Form 4 filed by Director Aguiar EricForm 4Grant or award
- Jun 20, 2025BBIODirector Aguiar Eric was granted 6,589 sharesForm 4Grant or award
- Jun 11, 2025BMEASEC Form 4 filed by Director Aguiar EricForm 4Grant or award
- Jun 21, 2024BBIOSEC Form 4 filed by Director Aguiar EricForm 4Grant or award
- Jun 12, 2024BMEASEC Form 4 filed by Director Aguiar EricForm 4Grant or award
- Jun 21, 2023BBIOSEC Form 4 filed by Aguiar EricForm 4Grant or award
- Jun 14, 2023BMEASEC Form 4 filed by Aguiar EricForm 4Grant or award
- Apr 27, 2023NVTASEC Form 4 filed by Aguiar EricForm 4Grant or award
- Jun 22, 2022BMEASEC Form 4 filed by Aguiar EricForm 4Grant or award
- Jun 22, 2022BBIOSEC Form 4 filed by Aguiar EricForm 4Grant or award
- Apr 28, 2022NVTASEC Form 4: Aguiar Eric was granted 43,400 shares, increasing direct ownership by 377% to 54,900 unitsForm 4Grant or award
- Jun 17, 2021BBIOSEC Form 4 filed by AGUIAR ERICForm 4Grant or award
- Apr 30, 2021NVTASEC Form 4: AGUIAR ERIC was granted 11,500 units of Common StockForm 4Grant or award
Also sits on boards with
Officers and directors who share two or more companies with Eric Aguiar.
Compare Eric Aguiar with
- Eric Aguiar vs Randal W. Scott2 shared
- Eric Aguiar vs Neil Kumar1 shared
- Eric Aguiar vs Thomas Trimarchi1 shared
- Eric Aguiar vs Maricel Apuli1 shared
- Eric Aguiar vs Andrea Ellis1 shared
- Eric Aguiar vs Jennifer E. Cook1 shared
Other insiders at the same companies
- Neil KumarBBIO
- Thomas TrimarchiBBIO
- Maricel ApuliBBIO
- Andrea EllisBBIO
- Jennifer E. CookBBIO
- Hannah ValantineBBIO
- Andrew LoBBIO
- Charles J HomcyBBIO
- Ronald J DanielsBBIO
- Fred HassanBBIO
- James C MomtazeeBBIO
- Frank MccormickBBIO
- Ali J. SatvatBBIO
- Douglas A. DachilleBBIO
- Sumita RayBMEA
Questions about Eric Aguiar
- What is Eric Aguiar's role at BridgeBio Pharma, Inc.?
- Eric Aguiar reports to the SEC as director at BridgeBio Pharma, Inc. (BBIO), according to the latest filing on June 24, 2026. Eric Aguiar has also filed as director at Biomea Fusion, Inc. (BMEA) and director at Invitae Corp (NVTA).
- How many shares does Eric Aguiar own?
- After the latest filing that states it, Eric Aguiar directly owned 10,579 shares of BridgeBio Pharma, Inc. (BBIO) and 125,322 shares of Invitae Corp (NVTA). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Eric Aguiar bought or sold stock recently?
- No open-market purchases or sales by Eric Aguiar are on file. The filings report grant or award.
- How do I get alerts when Eric Aguiar files?
- Follow Eric Aguiar on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Eric Aguiar (SEC CIK 0001262325). Totals count each trade once, skipping amendments whose original is on file, from May 4, 2021 on. View on SEC EDGAR · Get this as JSON